Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
Por:
Gallego-Durán R, Albillos A, Ampuero J, Arechederra M, Bañares R, Blas-García A, Berná G, Caparrós E, Delgado TC, Falcón-Pérez JM, Francés R, Fernández-Barrena MG, Graupera I, Iruzubieta P, Nevzorova YA, Nogueiras R, Macías RI, Marín F, Sabio G, Soriano G, Vaquero J, Cubero FJ and Gracia-Sancho J
Publicada:
1 nov 2022
Ahead of Print:
3 mar 2022
Resumen:
This is a meeting report of the 3rd Translational Hepatology Meeting held in Alicante, Spain, in October 2021. The meeting, which was organized by the Spanish Association for the Study of the Liver (AEEH), provided an update on the recent advances in the field of basic and translational hepatology, with a particular focus on the molecular and cellular mechanisms and therapeutic targets involved in metabolic-associated fatty liver disease (MAFLD), metabolic-associated steatohepatitis (MASH), cirrhosis and end-stage hepatocellular carcinoma (HCC).
Filiaciones:
Gallego-Durán R:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
SeLiver Group, Instituto de Biomedicina de Sevilla/Consejo Superior de Investigaciones Científicas (CSIC)/Universidad de Sevilla, Sevilla, Spain
Albillos A:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
Gastroenterology and Hepatology Department, Ramón y Cajal Hospital/ Alcalá University/ IIS Ramón y Cajal (IRYCIS), Madrid, Spain
Ampuero J:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
SeLiver Group, Instituto de Biomedicina de Sevilla/Consejo Superior de Investigaciones Científicas (CSIC)/Universidad de Sevilla, Sevilla, Spain
Virgen del Rocío Hospital, Sevilla, Spain
Arechederra M:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
Program of Hepatology. Centre of Applied Medical Research (CIMA). University of Navarra, Pamplona, Spain
IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
Bañares R:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
Gregorio Marañón Hospital, Madrid, Spain
IIS Gregorio Marañón (IiSGM), Madrid, Spain
Department of Medicine, Complutense Univeristy School of Medicine, Madrid, Spain
Blas-García A:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
FISABIO - University Hospital Dr Peset, Valencia, Spain
Department of Physiology, Faculty of Medicine, University of Valencia, Valencia, Spain
Berná G:
Biomedical Research Network on Diabetes and Related Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
Andalusian Center of Molecular Biology and Regenerative Medicine-CABIMER, Seville, Spain
University Pablo Olavide-University of Seville-CSIC, Seville, Spain
:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
Clinical Medicine Department, Miguel Hernández University, San Juan De Alicante, Spain
IIS Isabial, Alicante General Hospital, Alicante, Spain
Delgado TC:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain
Falcón-Pérez JM:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
Exosomes Laboratory & Metabolomics Platform, Center for Cooperative Research in Biosciences (CIC bioGUNE), Derio, Spain
Basque Foundation for Sciences, Ikerbasque, Bilbao, Spain
:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
Clinical Medicine Department, Miguel Hernández University, San Juan De Alicante, Spain
IIS Isabial, Alicante General Hospital, Alicante, Spain
Fernández-Barrena MG:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
Program of Hepatology. Centre of Applied Medical Research (CIMA). University of Navarra, Pamplona, Spain
IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
Graupera I:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
Liver Unit, Hospital Clínic de Barcelona. IDIBAPS Biomedical Research Institute, Barcelona, Spain
Iruzubieta P:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
Aparato Digestivo, Marqués de Valdecilla Hospital, Santander, Spain
Nevzorova YA:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
IIS Gregorio Marañón (IiSGM), Madrid, Spain
Department of Immunology, Opthalmology and ENT, Complutense University School of Medicine, Madrid, Spain
Department of Internal Medicine III, University Hospital RWTH, Aachen, Germany
Nogueiras R:
Biomedical Research Network on Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
Department of Physiology, CIMUS, University of Santiago de Compostela, Spain
IIS Santiago de Compostela, Spain
Macías RI:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
Experimental Hepatology and Drug Targeting (HEVEPHARM) Group, University of Salamanca, IBSAL, Salamanca, Spain
Marín F:
Biomedical Research Network on Diabetes and Related Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
Andalusian Center of Molecular Biology and Regenerative Medicine-CABIMER, Seville, Spain
University Pablo Olavide-University of Seville-CSIC, Seville, Spain
Sabio G:
Myocardial Pathophysiology, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
Soriano G:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Vaquero J:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
IIS Gregorio Marañón (IiSGM), Madrid, Spain
Cubero FJ:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
IIS Gregorio Marañón (IiSGM), Madrid, Spain
Department of Immunology, Opthalmology and ENT, Complutense University School of Medicine, Madrid, Spain
Gracia-Sancho J:
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
Liver Vascular Biology, IDIBAPS Biomedical Research Institute, Barcelona, Spain
Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland
Green Published, hybrid
|